First-in-human Electroporation Ablation Study Finds Pulsed Electric Fields Can Target Specific Tissue For Atrial Fibrillation. #HRS2018 #HRS18

Figure 1: Images showing the effect of both surgical epicardial PEF ablation and catheter based PEF ablation in the first-in-human electroporation ablation study to freat Afib.

News | May 25, 2018

May 25, 2018 — Data from the first-in-human study using pulsed electric field (PEF) energy ablate heart tissue in...

Tendyne Transcatheter Mitral Valve Replacement Device Demonstrates Positive 30-Day Outcomes
News | Heart Valve Technology | May 25, 2018

May 25, 2018 — Abbott announced favorable outcomes from the first 100 patients treated in a...

Abbott's Xience Sierra Stent Receives FDA Approval
Technology | Stents Drug Eluting | May 25, 2018

May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience...

Atrial Fibrillation Patients Diagnosed With Carotid Atery Disease Face Increased Risk of Dementia

Image courtesy of Intermountain Medical Center Heart Institute

News | Atrial Fibrillation | May 24, 2018

May 24, 2018 — Atrial...

Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy
News | Leads Implantable Devices | May 24, 2018

May 24, 2018 - Medtronic plc announced results from a...

Avinger Receives FDA Clearance of Next-Generation Pantheris Device
Technology | Atherectomy Devices | May 24, 2018

May 24, 2018 — Avinger Inc. announced that the company received 510(k) clearance from the U.S. Food & Drug...

Renal Denervation Shows Significant Drop in Hypertension
News | Renal Denervation | May 23, 2018

May 23, 2018 – At the 2018 EuroPCR Annual Meeting in Paris, Medtronic plc announced first-ever-data from the SPYRAL...

Medtronic to Discontinue SEEQ MCT Wearable Telemetry System
News | Wearable Sensors | May 23, 2018

May 23, 2018 — Medtronic announced on May 23, 2018 that it will discontinue marketing for its SEEQ Mobile Cardiac...

The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring

New cardiac monitoring technologies allow for longer duration data collection. The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring for up to three years. This might not be necessary for most patients, and there are several newer Holter monitors that can record up to several days or several weeks of data in real-time.  

Blog | ECG Wireless Remote Access | May 23, 2018

New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and...

Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018

May 23, 2018 — Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel...

Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018

May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...

LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018

May 22, 2018 — LuxCath LLC showcased the next generation of its proprietary OmniView light-guided...

Overlay Init